Stocks of Teladoc Health Inc (NYSE:TDOC) traded higher last session on Wall Street, up 2.66% to $17.38.
According to the data, Teladoc Health Inc (NYSE:TDOC) has 26 analysts covering its stock. The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $34.00 and a low of $16.00, we find $22.00. Given the previous closing price of $16.93, this indicates a potential upside of 29.95 percent. TDOC stock price is now -11.64% away from the 50-day moving average and -28.35% away from the 200-day moving average. The market capitalization of the company currently stands at $2.88B.
A total of 20 analysts have issued a hold rating and 6 have given it a buy rating. Brokers who have rated the stock have averaged $22.80 as their price target over the next twelve months.
With the price target of $25, Stephens recently initiated with Equal-Weight rating for Teladoc Health Inc (NYSE: TDOC).
In other news, Kornwasser Laizer, PRESIDENT, ENTERPRISE GROWTH sold 35,887 shares of the company’s stock on Nov 02. The stock was sold for $611,730 at an average price of $17.05. Upon completion of the transaction, the PRESIDENT, ENTERPRISE GROWTH now directly owns 44,907 shares in the company, valued at $0.78 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 02, CHIEF OPERATING OFFICER Waters Michael Willem sold 5,482 shares of the business’s stock. A total of $93,446 was realized by selling the stock at an average price of $17.05. This leaves the insider owning 31,774 shares of the company worth $0.55 million. Insiders disposed of 196,276 shares of company stock worth roughly $3.41 million over the past 1 year. A total of 0.71% of the company’s stock is owned by insiders.
Friday’s opening bell rang with an opening price of $17.22 for Teladoc Health Inc (NYSE: TDOC). During the past 12 months, Teladoc Health Inc has had a low of $15.02 and a high of $34.73. As of last week, the company has a debt-to-equity ratio of 0.69, a current ratio of 3.37, and a quick ratio of 3.28. The fifty day moving average price for TDOC is $19.58 and a two-hundred day moving average price translates $24.22 for the stock.
The latest earnings results from Teladoc Health Inc (NYSE: TDOC) was released for Sep, 2023. According to the Health Information Services Company, earnings per share came in at -$0.4, beating analysts’ expectations of -$0.41 by 0.01. This compares to -$0.45 EPS in the same period last year. The net profit margin was -155.12% and return on equity was -95.88% for TDOC. The company reported revenue of $660.24 million for the quarter, compared to $611.4 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 7.99 percent. For the current quarter, analysts expect TDOC to generate $664.11M in revenue.
Teladoc Health Inc(TDOC) Company Profile
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company operates through two segments, Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its that licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.
